B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity
Open Access
- 1 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 69 (2), 163-174
- https://doi.org/10.1007/s00262-019-02451-4
Abstract
B7 homolog 4 (B7H4) is considered a negative regulator of immune responses, but the immunoregulatory role of B7H4 in the tumor microenvironment is not clear. Here, we assessed B7H4 expression cell types in human breast cancer tissues and addressed its potential mechanisms in the CD8 T cell immune response. The results from flow cytometry and immunohistochemistry demonstrated that B7H4 was highly expressed in 26 out of 30 (86.7%) breast invasive ductal carcinomas, and B7H4 surface expression on tumor cells was inversely correlated with CD8 T lymphocytes infiltration (p < 0.0001). In vivo, B7H4-overexpressing tumor cells showed enhanced tumor growth in immunocompetent mice with impaired CD8 T cell infiltration of the tumor. Further investigation showed that activation and expansion of CD8 T cells within the lymph nodes were suppressed in B7H4-overexpessing tumor-bearing mice. An in vitro killing assay showed that the cytotoxicity of CD8 T cells was inhibited in B7H4-overexpressing tumor cells. These findings suggest that B7H4 in tumor cells is a negative regulator of CD8 T cell activation, expansion and cytotoxicity, indicating that tumor cell-associated B7H4 might be a target for T cell-based cancer immunotherapy.Funding Information
- the Natural Science Foundation of Fujian Province (2017J01525)
- the Key Research Program of Fujian Provincial Heath and Education Joint Committee (WKJ2016-2-31)
This publication has 22 references indexed in Scilit:
- 17th International Congress of Immunology, 19–23 October 2019, Beijing, ChinaEuropean Journal of Immunology, 2019
- Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor ResponsesCancer Research, 2013
- B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune ResponseClinical Cancer Research, 2011
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeProceedings of the National Academy of Sciences of the United States of America, 2007
- Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian CarcinomaCancer Research, 2007
- B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survivalProceedings of the National Academy of Sciences of the United States of America, 2006
- Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 FamilyThe Journal of Immunology, 2003
- B7x: A widely expressed B7 family member that inhibits T cell activationProceedings of the National Academy of Sciences of the United States of America, 2003
- B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell ImmunityImmunity, 2003
- B7S1, a Novel B7 Family Member that Negatively Regulates T Cell ActivationImmunity, 2003